Comparison of %5 Dextrose and Betamethasone Injections in Patients With Carpal Tunnel Syndrome

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-05-05

Study Completion Date

2024-05-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to compare the effectiveness of ultrasound-guided betamethasone and 5% dextrose injection, which is routinely applied in clinical practice, in patients with mild and moderate carpal tunnel syndrome (CTS).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Ultrasound-Guided 5% Dextrose Injection for Carpal Tunnel Syndrome

NCT06349265

Carpal Tunnel Syndrome

COMPLETED PHASE4

Comparison of Injection Techniques in Carpal Tunnel Syndrome

NCT07105540

Carpal Tunnel Syndrome

ENROLLING_BY_INVITATION PHASE4

Short Term Efficacy of 5% Dextrose Injection With Ultrasound Guided Nerve Hydrodissection Method in CTS

NCT06189651

Carpal Tunnel Syndrome

COMPLETED NA

Comparing Efficacies of Median Nerve Hydrodissection With Dexamethasone and Dextrose in Carpal Tunnel Syndrome

NCT06400433

Carpal Tunnel Syndrome Median Nerve Entrapment Entrapment Neuropathy

COMPLETED NA

Hydrodissection in Carpal Tunnel Syndrome

NCT07207460

Carpal Tunnel Syndrome Median Nerve Entrapment

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

It is planned as an observational, single-center clinical study.A total of 28 patients diagnosed with mild-moderate carpal tunnel syndrome who meet the inclusion criteria will be included in the study.Patients who had been experiencing trigger finger symptoms for at least three month and who presented to the Gaziler Physical Medicine and Rehabilitation Training and Research Hospital, affiliated with the Health Sciences University Faculty of Medicine.

Patients will be divided into two groups. One group will receive 5% dextrose, the other group will receive 1 session of local injection by mixing Celeston chronodose \[1ml/3 mg betamethasone acetate+3,947 mg betamethasone disodium phosphate (equivalent to 3 mg betamethasone)\] and 1 ml 2% prilocaine.

Evaluations will be made before injection, at weeks 4 and 12.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Carpal Tunnel Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

%5 dextrose group

%5 dextrose injection

Intervention Type PROCEDURE

hydrodissection with %5 dextrose

betamethasone group

betamethasone injection

Intervention Type PROCEDURE

perineural betamethasone injection

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

%5 dextrose injection

hydrodissection with %5 dextrose

Intervention Type PROCEDURE

betamethasone injection

perineural betamethasone injection

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Paresthesia and pain symptoms in the region corresponding to the distribution of the median nerve
* Detection of mild or moderate CTS by electromyography
* One or both of the Phalen test and/or Tinel sign are positive on physical examination
* Symptoms have persisted for at least 3 months

Exclusion Criteria

* Those diagnosed with polyneuropathy, plexopathy, radiculopathy, thoracic outlet syndrome
* Having had surgery or any injection for carpal tunnel syndrome within the last year
* History of wrist fracture
* Those with rheumatoid arthritis, uncontrolled diabetes, gout, chronic renal failure, malignancy, active systemic infection
* Those with cognitive impairment
* Coagulopathy or bleeding tendency
* Pregnancy

Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No